Analysis | Metabolite Name | Measured Value | Units | Group |
---|---|---|---|---|
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.1787 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.1787 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.1787 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.1866 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.2120 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.3009 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.3054 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.3112 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.3362 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.3529 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.3593 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.3725 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.3746 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.3748 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.3756 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.4082 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.4096 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.4244 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.4275 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.4307 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.4429 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.4767 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.4776 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.4817 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.4884 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.4944 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.5208 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.5212 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.5251 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.5291 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.5629 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.5814 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.6017 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.6054 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.6128 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.6237 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.6436 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.6608 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.6727 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.6763 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.7733 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.7949 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.8231 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.8250 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.8286 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.8295 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.8566 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.9219 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.9311 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.9388 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.9431 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.9619 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.9639 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.9815 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 0.9943 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.0057 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.0094 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.0097 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.0187 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.0572 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.0663 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.0858 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.1080 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.1234 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.1254 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.1421 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.1438 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.1605 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.1674 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.1707 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.1815 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.2498 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.2815 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.3039 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.3145 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.3159 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.3458 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.4029 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.5751 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.5923 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.6216 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.6271 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.6296 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.6364 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.6374 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.6871 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.7222 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.7642 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.8001 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.8227 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.8876 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 1.9531 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 2.0534 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 2.1065 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 2.2477 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 2.2886 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 2.3941 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 2.4030 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 2.4714 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 2.5087 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 2.6264 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 2.7435 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 2.7851 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 3.0041 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 3.5264 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 3.7008 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 5.2015 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N2-acetyllysine | 6.0404 | Peak area | Obese neuropathy |